Home NDC 43063-826 ACYCLOVIR
Product NDC 43063-826
11-digit product format 430630826
Labeler code 43063
Product ID 43063-826_de2184a8-33c8-c4cd-e053-2995a90ad314
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ACYCLOVIR
Dosage form CAPSULE
Route ORAL
Labeler PD-Rx Pharmaceuticals, Inc.
Application ANDA075677
Marketing category ANDA
Marketing start 2006-03-20
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record DailyMed Product Concepts# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 43063-826 ACYCLOVIR CAPSULE [PD-RX PHARMACEUTICALS, INC.] 13 Legacy NDC 20240703_38277d3a-1b38-4bc4-9dd5-6f0f7a237b85.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 43063-826-05 43063082605 5 CAPSULE in 1 BOTTLE, PLASTIC (43063-826-05) 5 capsule 2018-04-03 0000-00-00 No No Current 43063-826-50 43063082650 50 CAPSULE in 1 BOTTLE, PLASTIC (43063-826-50) 50 capsule 2018-01-18 0000-00-00 No No Current